305 related articles for article (PubMed ID: 11140104)
21. Retrospective evaluation of the influence of postoperative tumor marker status on survival and patterns of recurrence after surgery for pancreatic cancer based on RECIST guidelines.
Motoi F; Rikiyama T; Katayose Y; Egawa S; Unno M
Ann Surg Oncol; 2011 Feb; 18(2):371-9. PubMed ID: 20842460
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail.
Shimada K; Sakamoto Y; Sano T; Kosuge T
Surgery; 2006 Mar; 139(3):288-95. PubMed ID: 16546491
[TBL] [Abstract][Full Text] [Related]
23. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
[TBL] [Abstract][Full Text] [Related]
24. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
[TBL] [Abstract][Full Text] [Related]
25. Major pancreatic resections for suspected cancer in a community-based teaching hospital: lessons learned.
Metreveli RE; Sahm K; Abdel-Misih R; Petrelli NJ
J Surg Oncol; 2007 Mar; 95(3):201-6. PubMed ID: 17323334
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic head carcinoma: clinical analysis of 189 cases.
Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
[TBL] [Abstract][Full Text] [Related]
27. Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care.
Smoot RL; Zhang L; Sebo TJ; Que FG
J Am Coll Surg; 2008 Sep; 207(3):368-70. PubMed ID: 18722942
[TBL] [Abstract][Full Text] [Related]
28. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.
Reddy S; Wolfgang CL; Cameron JL; Eckhauser F; Choti MA; Schulick RD; Edil BH; Pawlik TM
Ann Surg; 2009 Aug; 250(2):282-7. PubMed ID: 19638918
[TBL] [Abstract][Full Text] [Related]
29. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe?
Jang JY; Kim SW; Lee SE; Yang SH; Lee KU; Lee YJ; Kim SC; Han DJ; Choi DW; Choi SH; Heo JS; Cho BH; Yu HC; Yoon DS; Lee WJ; Lee HE; Kang GH; Lee JM
Ann Surg Oncol; 2008 Jan; 15(1):199-205. PubMed ID: 17909912
[TBL] [Abstract][Full Text] [Related]
30. [Resective surgical treatment of exocrine pancreas neoplasms. Retrospective study of 294 cases and review of the literature].
Proposito D; Santoro R; Mancini B; Gallina S; Carboni M
Ann Ital Chir; 1998; 69(1):49-62. PubMed ID: 11995039
[TBL] [Abstract][Full Text] [Related]
31. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection.
Partelli S; Crippa S; Barugola G; Tamburrino D; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
Ann Surg Oncol; 2011 Dec; 18(13):3608-14. PubMed ID: 21584836
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
[TBL] [Abstract][Full Text] [Related]
33. [Palliative surgery in nonresectable pancreatic carcinoma].
Guglielminetti D; Burgini M; Gaddoni G; Polacchini G; Fiorentini G
G Chir; 1994 Oct; 15(10):439-42. PubMed ID: 7531479
[TBL] [Abstract][Full Text] [Related]
34. Clinical results of extended lymphadenectomy and intraoperative radiotherapy for pancreatic adenocarcinoma.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Tanizawa Y
Hepatogastroenterology; 2007 Mar; 54(74):564-9. PubMed ID: 17523323
[TBL] [Abstract][Full Text] [Related]
35. [Results of resection for ductal adenocarcinoma of the pancreatic head].
Morin B; Chiche L; Salame E; Lebreton G; Rouleau V; Segol P
Ann Chir; 2006 Nov; 131(9):518-23. PubMed ID: 17045233
[TBL] [Abstract][Full Text] [Related]
36. [Is resection of left-sided ductal pancreatic carcinoma of value?]].
Gebhardt C; Meyer W; Jurowich C
Zentralbl Chir; 2000; 125(12):966-9. PubMed ID: 11190614
[TBL] [Abstract][Full Text] [Related]
37. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy.
Barugola G; Partelli S; Crippa S; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
Am J Surg; 2012 Feb; 203(2):132-9. PubMed ID: 21824596
[TBL] [Abstract][Full Text] [Related]
38. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
Ghaneh P; Neoptolemos JP
Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
[TBL] [Abstract][Full Text] [Related]
39. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
40. Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma.
Moutardier V; Magnin V; Turrini O; Viret F; Hennekinne-Mucci S; Gonçalves A; Pesenti C; Guiramand J; Lelong B; Giovannini M; Monges G; Houvenaeghel G; Delpero JR
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):437-43. PubMed ID: 15380577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
